创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

GUO Yingrui, QIAN Ruiyi, YU Shunying, SHEN Yifeng, ZHAO Xue. Antipsychotics/Antidepressants and Restless Legs Syndrome[J]. Progress in Pharmaceutical Sciences, 2025, 49(6): 410-416. DOI: 10.20053/j.issn1001-5094.20250030
Citation: GUO Yingrui, QIAN Ruiyi, YU Shunying, SHEN Yifeng, ZHAO Xue. Antipsychotics/Antidepressants and Restless Legs Syndrome[J]. Progress in Pharmaceutical Sciences, 2025, 49(6): 410-416. DOI: 10.20053/j.issn1001-5094.20250030

Antipsychotics/Antidepressants and Restless Legs Syndrome

  • Restless legs syndrome (RLS), one of common adverse effects of antipsychotics and antidepressants, affect the patients’ quality of sleep, aggravate their psychiatric symptoms, and reduce their quality of life, yet it still has not been widely emphasized in clinical practice. This article provides a review of the possible mechanisms and related treatment methods of RLS caused by antipsychotic and antidepressant drugs, aiming to provide reference for the clinical treatment of RLS.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return